Hematopoietic cell transplantation in Latin America

Hematology

Volumn 17, Issue SUPPL. 1, 2012, Pages

  Eckrich, Michael ^a   Pasquini, Marcelo ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Activity; Latin America; Transplant

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARGENTINA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD DONOR; BRAZIL; CHRONIC MYELOID LEUKEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; FANCONI ANEMIA; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH PROGRAM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTERNATIONAL COOPERATION; LYMPHOMA; MEXICO; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; REGISTER; STEM CELL RESEARCH; TOTAL QUALITY MANAGEMENT; TREATMENT INDICATION;

ADULT; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LATIN AMERICA; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS;

EID: 84859778693     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453312X13336169157059     Document Type: Article

References (10)

1. Pasquini MC, Wang Z, Horowitz M, Gale RP. 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplant for blood and bone marrow disorders. In: Cecka JM, Terazaki PI, editors. Clinical transplants 2010. Los Angeles (CA): The Terasaki Foundation Laboratory; 2011. p. 87-105.
2. Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano-Ispizua A. Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol. 2002;117(2):451-68.
3. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010;303(16):1617-24.
4. Ruiz-Arguelles GJ. Allogeneic stem cell transplantation using non-myeloablative conditioning regimens: results of the Mexican approach. Int J Hematol. 2002;76 Suppl 1:376-9.
5. Ruiz-Arguelles GJ, Gomez-Almaguer D, Morales-Toquero A, Gutierrez-Aguirre CH, Vela-Ojeda J, Garcia-Ruiz-Esparza MA, et al. The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter study. Bone Marrow Transplant. 2005;36(12):1043-7.
6. Hamerschlak N, Maluf E, Pasquini R, Eluf-Neto J, Moreira FR, Cavalcanti AB, et al. Incidence of aplastic anemia and agranulocytosis in Latin America-the LATIN study. Sao Paulo Med J. 2005;123(3):101-4.
7. Maluf EM, Pasquini R, Eluf JN, Kelly J, Kaufman DW. Aplastic anemia in Brazil: incidence and risk factors. Am J Hematol. 2002;71(4):268-74.
8. Maluf E, Hamerschlak N, Cavalcanti AB, Junior AA, Eluf-Neto J, Falcao RP, et al. Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study. Haematologica. 2009;94(9):1220-6.
9. Bonfim CM, de Medeiros CR, Bitencourt MA, Zanis-Neto J, Funke VA, Setubal DC, et al. HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide. Biol Blood Marrow Transplant. 2007;13(12):1455-60.
10. Yates J, Keeble W, Pals G, Ameziane N, van Spaendonk R, Olson S, et al. Novel inactivating mutations of FANCC in Brazilian patients with Fanconi anemia. Hum Mutat. 2006;27(2):214.